Compare CBFV & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CBFV | ORMP |
|---|---|---|
| Founded | 1901 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 174.1M | 165.3M |
| IPO Year | 2014 | 2010 |
| Metric | CBFV | ORMP |
|---|---|---|
| Price | $37.00 | $5.08 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $38.00 | N/A |
| AVG Volume (30 Days) | 3.7K | ★ 238.1K |
| Earning Date | 04-22-2026 | 05-14-2026 |
| Dividend Yield | 3.12% | ★ 6.51% |
| EPS Growth | N/A | ★ 412.50 |
| EPS | 0.73 | ★ 0.91 |
| Revenue | ★ $43,557,000.00 | $2,000,000.00 |
| Revenue This Year | $48.93 | N/A |
| Revenue Next Year | $7.97 | N/A |
| P/E Ratio | $51.03 | ★ $5.49 |
| Revenue Growth | N/A | ★ 49.25 |
| 52 Week Low | $27.49 | $1.98 |
| 52 Week High | $37.95 | $5.19 |
| Indicator | CBFV | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 59.87 | 68.02 |
| Support Level | $34.06 | $3.21 |
| Resistance Level | $37.75 | $5.01 |
| Average True Range (ATR) | 1.04 | 0.24 |
| MACD | 0.10 | 0.12 |
| Stochastic Oscillator | 82.28 | 74.09 |
CB Financial Services Incis a bank holding company headquartered in Carmichaels, Pennsylvania. The company had one reportable segment, community banking services. The Bank also has a loan production office in Allegheny County, a loan production office and a corporate center in Washington County, and an operations center in Greene County, Pennsylvania. The Bank is a community-oriented institution offering residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a variety of deposit products for individuals and businesses in its market area.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.